Clinical Trial Update: A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing two oral semaglutide formulations for safety and efficacy in reducing blood glucose in Japanese adults with Type 2 Diabetes has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• oral semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED